A share price of VolitionRX Ltd [VNRX] is currently trading at $288580.0, up 1692954%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VNRX shares have gain 54.36% over the last week, with a monthly amount glided 87.37%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
VolitionRX Ltd [AMEX: VNRX] stock has seen the most recent analyst activity on April 08, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $2.50. Previously, The Benchmark Company downgraded its rating to Hold on February 01, 2023. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $8 on March 10, 2021. Maxim Group initiated its recommendation with a Buy and recommended $6 as its price target on May 16, 2018. The Benchmark Company reiterated a Buy rating for this stock on May 14, 2018, and downed its price target to $5. In a note dated September 07, 2016, Rodman & Renshaw reiterated an Buy rating on this stock and revised its target price from $12 to $10.
VolitionRX Ltd experienced fluctuations in its stock price throughout the past year between $0.40 and $0.90. VolitionRX Ltd [AMEX: VNRX] shares were valued at $288580.0 at the most recent close of the market.
Analyzing the VNRX fundamentals
Trailing Twelve Months sales for VolitionRX Ltd [AMEX:VNRX] were 1.31M which represents 43.64% growth. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at -14.25%, Pretax Profit Margin comes in at -18.5%, and Net Profit Margin reading is -18.36%. To continue investigating profitability, this company’s Return on Assets is posted at -2.82, Equity is 1.08 and Total Capital is -75.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for VolitionRX Ltd [AMEX:VNRX] is 0.40. Also, the Quick Ratio is 0.40, while the Cash Ratio stands at 0.31. Considering the valuation of this stock, the price to sales ratio is 72.35.
Transactions by insiders
Recent insider trading involved Reynolds Cameron John, President and CEO, that happened on Jun 12 ’25 when 12500.0 shares were purchased. Director, Innes Guy Archibald completed a deal on Jun 03 ’25 to buy 20000.0 shares. Meanwhile, Chief Scientific Officer Micallef Jacob Vincent bought 50000.0 shares on May 19 ’25.
